← Open Payments lookup

ERIKA LANCASTER: Open Payments

NPI 1053900936 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$604 in 31 payments from 16 companies in 2025. Trend: 2023 $90 · 2024 $813 · 2025 $604

Food & beverage: $604
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$149
Indivior Inc.5$85
Corcept Therapeutics3$59
Lilly USA, LLC2$37
ABBVIE INC.2$35
Amgen Inc.2$34
Merck Sharp & Dohme LLC1$26
Axsome Therapeutics, Inc.1$23
Exact Sciences Corporation1$23
PFIZER INC.1$22

Products named: FARXIGA, SUBLOCADE, Korlym, MOUNJARO, VRAYLAR, OTEZLA, VERQUVO, Auvelity.

Industry payments across AL — which companies pay providers there.